The Efficacy of Botulinum Toxin in Disabling Multiple Sclerosis (MS) Tremor

PHASE3CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

February 28, 2010

Study Completion Date

June 30, 2010

Conditions
Multiple SclerosisTremor
Interventions
DRUG

Botulinum Toxin Type A

Intramuscular injection in affected limb up to 100 Units. Two doses (one placebo, one active) 3 months apart.

Trial Locations (1)

3050

Melbourne Health, Melbourne

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Eastern Health

OTHER

lead

Melbourne Health

OTHER